e-Article
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
Document Type
Article
Author
Source
In: Journal of Experimental and Clinical Cancer Research . (Journal of Experimental and Clinical Cancer Research, December 2023, 42(1))
Subject
Language
English
ISSN
17569966